Congenital Myotonic Dystrophy Trial Now Recruiting

The NMD4C is excited to share that an international randomized, multicenter, double-blind, placebo-controlled, phase 2/3 clinical trial testing the safety and efficacy of Tideglusib in Congenital Myotonic Dystrophy (CDM) patients aged 6-16 has begun recruiting. This is the first CDM trial to take place in Canada, even though CDM is one of the more common neuromuscular diseases in Canada, affecting more than one in 50,000 live births. The two Canadian sites are the Children’s Hospital London Health Sciences Centre (LHSC) in London, ON and the Children’s Hospital of Eastern Ontario (CHEO) in Ottawa, ON, with Drs. Craig Campbell and Hanns Lochmüller as Principal Investigators.

Both the London and Ottawa sites are open for recruitment; contact information for both sites is located below. If you would like to learn more about the eligibility criteria and for further information, please visit the ClinicalTrials.gov site to find detailed information!

LHSC site: Rhiannon Hicks, , (519)-685-8441.

CHEO site: Emilie Hill-Smith, , 613-737-7600 ext. 4014.

Our network brings together clinicians, researchers, and people with neuromuscular disease across the country.

Read next...

NEWS_Advancing Neuromuscular Research 2025 NMD4C Publications 

Advancing Neuromuscular Research: 2025 NMD4C Publications 

Our network continues to grow, collaborate, and push the field forward, and these 2025 publications highlight the impact our community is making together

NEWS_ Nomination and Application Deadlines

2026 NMD4C Application & Nomination Deadlines

As we start the new year, three important NMD4C opportunities are approaching their deadlines. Members are invited to nominate a researcher or publication for the Annual NMD4C Awards, apply to join the Basic Science Trainee Committee (BSTC), and apply to attend the 2026 NMD4C Basic Research Summer School, taking place June 8–10 under the leadership of Dr. Mireille Khacho. Registration for the summer school is free, with travel and accommodations covered for non‑local trainees.

Website - NMD 2026 Fellows

Announcing the 2026 Neuromuscular Postdoctoral Fellowship Funding Recipients! 

Together with Muscular Dystrophy Canada (MDC), we’re excited to share that the 2026 Neuromuscular Postdoctoral Research Fellows have been awarded! This year’s competition provided salary support for two exceptional early‑career scientists to pursue postdoctoral research in Canadian laboratories dedicated to advancing neuromuscular research. Successful applicants will receive $40,000 in funding over a one-year period.